In-Hospital Mortality, Length of Stay and Financial Toxicity for Patients Undergoing Hematopoietic Stem Cell Transplant in the United States: A Retrospective cohort study and National Estimates | Synapse
March 3, 2026
In-Hospital Mortality, Length of Stay and Financial Toxicity for Patients Undergoing Hematopoietic Stem Cell Transplant in the United States: A Retrospective cohort study and National Estimates
Key Points
In-hospital mortality for patients undergoing hematopoietic stem cell transplant was analyzed, revealing financially severe implications.
Key findings indicate a substantial increase in financial toxicity, affecting patient outcomes in transplant scenarios.
Retrospective cohort data was utilized to evaluate length of stay and mortality rates during transplant procedures across the U.S.
Findings underscore economic challenges facing patients, suggesting the need for better financial support and resources.